Axa S.A. Unity Biotechnology, Inc. Transaction History

Axa S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.91 - $4.5 $61,110 - $94,500	-21,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$4.15 - $6.3 $403,380 - $612,360	-97,200 Reduced 82.23%	21,000 $97,000
Q1 2021 May 14, 2021	BUY	$5.51 - $9.42 $651,282 - $1.11 Million	118,200 New	118,200 $709,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $14M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.